Social determinants of health and their impact on equitable access to quality care took center stage at the Institute for ...

A cup of coffee a day did not worsen atrial fibrillation (AF) in adults recovering from electrical cardioversion, and it may even lower the likelihood of recurrent arrhythmia, according to new ...

A vote on the House floor allowed for the government to reopen immediately, but the fight over the extension of ACA subsidies still goes on.

Panelists discuss how recent FDA approvals and SC amivantamab data support broader use of subcutaneous therapy in NSCLC.

Ziftomenib (Komzifti; Kura Oncology and Kyowa Kirin), an oral, once-daily, selective menin inhibitor, has received approval from the FDA for the treatment of adult patients with relapsed or refractory ...

Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.

Children who undergo primary congenital glaucoma surgery had better visual acuity (VA) when wearing contact lenses compared with spectacles.

Panelists discuss how SC delivery enhances patient convenience and health care efficiency in NSCLC treatment.

The TCC and Intermountain Health partnership provides local cancer care in Fairbanks, reducing travel for Alaska Native ...

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while ...

Nipocalimab shows promise in treating myasthenia gravis in children, with ongoing trials revealing safety and efficacy ...

F32 grants from the National Institutes of Health (NIH) help early-career physician-scientists launch research careers, ...